Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency

Haematologica

Volumn 96, Issue 12, 2011, Pages 1892-1894

  Ripperger, Tim ^a   Tauscher, Marcel ^a   Haase, Detlef ^b   Griesinger, Frank ^c   Schlegelberger, Brigitte ^a   Steinemann, Doris ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c PIUS HOSPITAL   (Germany)

Author keywords

Fpdmm; Germline runx1 deficiency

Indexed keywords

DNA; TRANSCRIPTION FACTOR RUNX1;

ADULT; ANEMIA; BLOOD CELL COUNT; BONE MARROW CELL; CASE REPORT; CHROMOSOME 21Q; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PREDISPOSITION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENETIC COUNSELING; GENOME SIZE; GERM LINE; HEMATOLOGIC MALIGNANCY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; KARYOTYPING; LETTER; MYELODYSPLASTIC SYNDROME; MYELOMA; NEUTROPENIA; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PROTEIN DEFICIENCY; RUNX1 GENE; THROMBOCYTOPENIA;

HUMANS; MYELODYSPLASTIC SYNDROMES;

EID: 82855172176     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.053710     Document Type: Letter

References (8)

1. Liew E, Owen CJ. Familial myelodysplastic syndromes - a review of the literature. Haematologica. 2011;96(10):1536-42.
2. van der Crabben S, van Binsbergen E, Ausems M, Poot M, Bierings M, Buijs A. Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation. Leuk Res. 2010;34:e8-e12.
3. Ripperger T, Steinemann D, Gohring G, Finke J, Niemeyer CM, Strahm B, et al. A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? Leukemia. 2009;23(7):1364-6.
4. Preudhomme C, Renneville A, Bourdon V, Philippe N, Roche-Lestienne C, Boissel N, et al. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood 2009;113(22):5583-7.
5. Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364(26):2496-506.
6. Owen CJ, Toze CL, Koochin A, Forrest DL, Smith CA, Stevens JM, et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood 2008;112(12):4639-45.
7. Shinawi M, Erez A, Shardy DL, Lee B, Naeem R, Weissenberger G, et al. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q. Blood 2008;112(4):1042-7.
8. Katzaki E, Morin G, Pollazzon M, Papa FT, Buoni S, Hayek J, et al. Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patients. Am J Med Genet A 2010;152A(7):1711-7.